4bases kits work on all first generation and next generation systems. Current 4bases kits for breast, ovarian, colorectal, lung and thyroid cancer are designed to identify genetic anomalies of the cancer to direct drug therapy decisions. 4bases has developed also a kit for the investigation of hereditary mutations involved in breast and ovarian cancer predisposition. In addition, 4bases will design and produce diagnostic assays based on NGS technology for no oncological diseases. 


Companion diagnostic assays in oncology

Read more +

CE-IVD data analysis software

Read more +






4bases S.A. is a company founded in 2013 to develop and produce CE IVD companion diagnostic tests for oncological diseases. The company is certificated ISO 13485 by Kiwa Cermet Italia S.p.a..

4bases has its head office in Manno, Ticino, Switzerland.  4bases S.A. has an italian branch, 4bases Italia Srl, that manufactures molecular diagnostic kits on behalf of 4bases S.A..


The Mission of 4bases is bring effective personalized medicine to global health by translating genomic research into clinical applications, providing cost effective, clinically valid and diagnostically applicable NGS platform independet solutions. 



For any inquiries,
please call or email us:

IconaTelefono +41 445867640
4bases SA

c/o Tecnopolo Ticino
Via Cantonale 18
CH-6928 Manno, Switzerland

4bases Italia S.r.l.
Italian manufacturing branch

Via San Contardo 27
27040 Campospinoso, Italy